Saratov JOURNAL of Medical and Scientific Research

Endovascular treatment for critical limb ischemia in patients with diabetes mellitus (review)

Year: 2019, volume 15 Issue: №4 Pages: 873-876
Heading: Surgery Article type: Review
Authors: Bakhmetyev A.S., Anisimova Е.А., Temerezov T.Kh., Zotkin V.V., Rudakov M.O.
Organization: Medical Di Center, Regional Vascular Center of the Karachay-Cherkess Republican Clinical Hospital, Saratov State Medical University

The literature review is devoted to the contemporary possibilities of endovascular surgery for patients with critical lower limb ischemia and diabetes mellitus. Surgical indications based on non-invasive methods such as measuring ankle-brachial and shoulder-finger indexes, as well as transcutaneous oximetry are considered. The material outlines both positive and negative aspects of interventional surgery in this cohort of patients included in the group of extremely high atherosclerotic risk.

1. Dedov II, Shestakova MV, Mayorov AY, eds. Standards of specialized diabetes care. 8th edition. Moscow, 2017. 112 p.
2. Schaper NC, Andros G, Apelqvist J, et al. Specific guidelines for the diagnosis and treatment of peripheral arterial disease in a patient with diabetes and ulceration of the foot 2011. Diabetes Metab Res Rev 2012; 28 (1): 236-7. DOI: 10.1002/dmrr. 2252.
3. Baumann F, Engelberger RP, Willenberg T, et al. Infrapopliteal lesion morphology in patients with critical limb ischemia: implications for the development of anti-restenosis technologies. J Endovasc Ther 2013; 20 (2): 149-56. DOI: 10.1583/1545-1550-20.2.149.
4. Levis K. Multidrug tolerance of biofilms and persister cells. CurrTop Microbiol Immunol 2018; 322: 107-31.
5. Miyajima S, Shirai A, Yamamoto S. Risk factors for major amputations in diabetic foot gangrene patients. Diabetes Res Clin Pract 2016; 7 (3): 272-9.
6. Митиш В.A., Махкамова Ф.Т., Пасхалова Ю.С. и др. Фактическая стоимость комплексного хирургического лечения больных нейроишемической формой синдрома диабетической стопы. Хирургия: Журнал им. Н.И. Пирогова 2015; 4: 48-53. DOI: 10.17116/hirurgia2015448-53.
7. Оболенский B.H., Никитин В. Г., Ле-валь П.Ш. и др. Лечебно-диагностический алгоритм при синдроме диабетической стопы: стандарты и новые технологии. РМЖ: Хирургия 2012; 12: 585-98.
8. Черданцев Д. В., Николаева Л. П., Степаненко А. В., Константинов Е. П. Диабетические макроангиопатии: методы восстановления кровотока. Фундаментальные исследования 2010; 1: 95-9.
9. Tendera М, Aboyans V, et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC)/European Stroke Organisation. Eur Heart J 2011; 32 (22): 2851-906.
10. Boyko EJ, Seelig AD, Ahroni JH. Limb- and person-level risk factors for lower-limb amputation in the prospective Seattle diabetic foot study. Diabetes Care 2018; 41 (4): 891-8. DOI: 10.2337/dc17-2210.
11. Mohammedi K, Woodward M, Hirakawa Y, et al. Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study. Cardiovasc Diabetol 2016; 15 (1): 129. DOI: 10.1186/sl 2933-016-0446-x.
12. Althouse AD, Abbott JD, Forker AD, et al. Risk factors for incident peripheral arterial disease in type 2 diabetes: results from the Bypass Angioplasty Revascularization Investigation in type 2 Diabetes (BARI 2D). Trial Diabetes Care 2014; 37 (5): 1346-52. DOI: 10.2337/dc13-230.
13. Han E, Lee YH, Lee BW, et al. Anatomic fat depots and cardiovascular risk: a focus on the leg fat using nationwide surveys (KNHANES 2008-2011). Cardiovasc Diabetol 2017; 16 (1): 54. DOI: 10.1186/s12933-017-0536-4.
14. Malmstedt J, Karvestedt L, Swedenborg J, Brismar K. The receptor for advanced glycation end products and risk of peripheral arterial disease, amputation or death in type 2 diabetes: a population-based cohort study. Cardiovasc Diabetol 2015; 14: 93. DOI: 10.1186/s12933-015-0257-5.
15. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vase Endovasc Surg 2007; 33 Suppl 1: S1-75. DOI: 10.1016/j. ejvs. 2006.09.024.
16. Graziani L, Silvestro A, Bertone V, et al. Vascular involvement in diabetic subjects with ischemic foot ulcer: A new morphologic categorization of disease severity. Eur J Vase Endovasc Surg 2007; 33 (4): 453-60. DOI: 10.1016/j. ejvs. 2006.11.022.
17. Abu Dabrh AM, Steffen MW, Undavalli C, et al. The natural history of untreated severe or critical limb ischemia. J Vase Surg 2015; 62 (6): 1642-51.
18. Stegemann E, Tegtmeier C, Bimpong-Buta NY, et al. Carbondioxide-aided angiography decreases contrast volume and preserves kidney function in peripheral vascular interventions. Angiology 2016; 67 (9): 875-81.
19. Willigendael EM, Teijink JA, Bartelink ML, et al. Smoking and the patency of lower extremity bypass grafts: a meta-analysis. J Vase Surg 2015; 42 (1): 67-74.
20. Ingle H, Nasim A, Bolia A, et al. Subintimal angioplasty of isolated infragenicular vessels in lower limb ischemia: long-term results. J Endovasc Ther 2002; 9: 411-6.
21. Fiordaliso F, Clerici G, Maggioni S, et al. Prospective study on microangiopathy in type 2 diabeticfoot ulcer. Diabetologia 2016; 59 (7): 1542-8. DOI: 10.1007/s00125-016-3961-0.
22. Luders F, Bunzemeier H, Engelbertz C, et al. CKD and acute and long-term outcome of patients with peripheral artery disease and critical limb ischemia. Clin J Am Soc Nephrol 2016; 11 (2): 216-22. DOI: 10.2215/CJN. 05600515.
23. Jamsen T, Manninen H, Tulla H, Matsi P. The final outcome of primary infrainguinal percutaneous transluminal angioplasty in 100 consecutive patients with chronic critical limb ischemia. J Vase Interv Radiol 2002; 13: 455-63.
24. Maksimovich IV Transluminal laser angioplasty for ischemic brain lesions: DSc abstract. Moscow, 2004; 36 p.
25. Vraux Н, Bertoncello N. Subintimal angioplasty of tibial vessel occlusions in critical limb ischaemia: a good opportunity? Eur J Vase Endovasc Surg. 2006; 32 (6): 663-7.
26. Faglia E, Clereci G, Caminity M, et al. Heel ulcer and blood flow: the importance of the angiosome concept. Int J Low Extrem Wounds 2013; 12 (3): 226-30. DOI: 10.1177/1534734613502043.
27. Sheehan P, Jones P, Caselli A, et al. Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial. Diabetes Care 2003; 26 (6): 1879-82. DOI: 10.2337/diacare. 26.6.1879.
28. Faglia E, Clereci G, Cleressi J, et al. When is a technically successful peripheral angioplasty effective in preventing above-the-ankle amputation in diabetic patients with critical limb ischemia? Diabetes Med 2007; 24 (8): 823-9. DOI: 10.1016/j. ejvs. 2006.12.027.
29. Santoro L, Ferraro PM, Flex A, et al. New semiquantitative ultrasonographic score for peripheral arterial disease assessment and its association with cardiovascular risk factors. Hypertens Res 2016; 39 (12): 868-73. DOI: 10.1038/hr. 2016.88.
30. Santoro L, Flex A, NesciA, et al. Association between peripheral arterial disease and cardiovascular risk factors: role of ultrasonography versus ankle-brachial index. Eur Rev Med Pharmacol Sci 2018; 22 (10): 3160-5.
31. Bondarenko ON, Galstyan GR, Dedov IR. The clinical course of critical limb ischemia and the role of endovascular revascularization in patients with diabetes. Diabetes mellitus 2015; 18 (3): 57-69.
32. VerbovoyAF, Pashentseva AV, Verbovaya Nl. Diabetic macroangiopathy. Therapeutic Archive 2019; 91 (10): 139-43.

2019_04_873-876.pdf301.64 KB

No votes yet